By the close of trading Wednesday, Medline stock had risen 41.3% from its IPO price to $41. PitchBook analysts say private ...

Venezuela accounts for a small part of the global oil supply, producing about 1 million barrels per day, or just under 1%.

More recently, OCI’s strong client focus and ability to scale put it squarely at the center of the booming AI ecosystem, leading to skyrocketing bookings with key AI stakeholders such as OpenAI, Meta, ...

While Micron shares are up 168% so far this year, they fell for five straight sessions in the leadup to Wednesday's report, as investors have come to worry about the health of the AI trade thanks to ...

Fitch's downgrade follows Vanke's entry into a grace period of five working days for the repayment of principal and interest on the onshore bond, the rating company said, adding that Vanke expects to ...

The move - via the launch of a grocery-shopping app within the popular AI chatbot - makes DoorDash (DASH) the latest company to provide AI-driven purchases. And it comes ahead of plans by the company ...

Dow Jones Top Markets Headlines at 7 PM ET: AI-Themed Stocks Take More Hits, Sending Nasdaq Lower | Fed's ... Tech shares weighed on indexes; Oracle, Nvidia and Tesla dropped more than 3%. Fed's ...

Dow Jones Top Company Headlines at 7 PM ET: BP Turns to Outsider as Next CEO | Micron ... Meg O'Neill is resigning from her role leading Woodside Energy to become BP's CEO. Micron Logs Sales Jump, ...

Kelsian is one of the biggest operators of metropolitan bus services for state governments throughout Australia. It also runs private-sector transportation services for Australian resource companies ...

After the sale of Epsilon in 2019 and spinoff of LoyaltyOne in 2021, Bread Financial is solely a consumer credit company; its private-label credit card and buy now/pay later businesses are its only ...

Tesla is on track for its worst U.S. sales performance since 2022, and that's not the only region where the electric-vehicle maker is under pressure.

Johnson & Johnson's Rybrevant Faspro was approved as a treatment for people with lung cancer by the Food and Drug Administration. Rybrevant Faspro was approved across all indications for subcutaneous ...